Results 181 to 190 of about 46,160 (296)

Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2095-2104, March 2026.
Abstract Objective This observational study examined changes in mental health and wellbeing after 4‐months liraglutide 3.0 mg treatment in patients with obesity and explored associations with weight loss. Methods We included 98 patients with obesity treated with liraglutide 3.0 mg.
Susanne Kuckuck   +7 more
wiley   +1 more source

Managing the Complex Intersection Between Substance Use Disorders and Infectious Diseases

open access: yes
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 3, March 2026.
Karissa Chow   +4 more
wiley   +1 more source

Non‐steroidal anti‐inflammatory drugs versus acetaminophen and risk of venous thromboembolism: An active comparator new user cohort study

open access: yesJournal of Internal Medicine, Volume 299, Issue 3, Page 381-397, March 2026.
Abstract Background Previous observational studies have reported an increased risk of venous thromboembolism (VTE) among non‐steroidal anti‐inflammatory drug (NSAID) users compared with non‐users. However, these studies may have been subject to bias due to unmeasured confounders related to patient conditions requiring NSAIDs.
Yuichiro Matsuo   +2 more
wiley   +1 more source

The experience of body image in people with psychosis and psychotic‐like experiences: A co‐produced mixed‐methods systematic review and narrative synthesis

open access: yesPsychology and Psychotherapy: Theory, Research and Practice, Volume 99, Issue 1, Page 1-39, March 2026.
Abstract Purpose Body image is a transdiagnostic construct that seems poorly understood in psychosis. Poor body image is associated with paranoia, which makes it a theoretically meaningful treatment target in psychosis. We systematically reviewed associations between body image and psychosis symptoms in both the ‘general’ population and people living ...
Jenna McAllister   +10 more
wiley   +1 more source

Risks of dementia and stroke in patients with hypertension using telmisartan or other renin‑angiotensin system inhibitors

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract INTRODUCTION The aim of this study was to investigate the cognitive and cerebrovascular outcomes of patients with hypertension (HTN) receiving various renin‐angiotensin system (RAS) inhibitors. METHODS We further categorized 39,665 patients with HTN receiving long‐term RAS inhibitor therapy into (1) telmisartan, (2) non‐telmisartan angiotensin
Chi‐Hung Liu   +5 more
wiley   +1 more source

Urinary tract infection‐related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract Alzheimer's disease and related dementias (ADRD) affects millions of patients worldwide and is a leading cause of morbidity in older adults. Patients with ADRD are particularly susceptible to developing urinary tract infection (UTI) and UTI‐related delirium, creating a self‐perpetuating cycle in which ADRD increases vulnerability to infection ...
Sarah Kim   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy